Vestmark Advisory Solutions’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-24,892
Closed -$119K 886
2022
Q3
$119K Buy
24,892
+392
+2% +$2.07K 0.01% 803
2022
Q2
$110K Buy
24,500
+10,156
+71% +$44.1K 0.01% 827
2022
Q1
$68K Sell
14,344
-180
-1% -$997 ﹤0.01% 851
2021
Q4
$108K Sell
14,524
-399
-3% -$2.48K 0.01% 833
2021
Q3
$85K Buy
14,923
+193
+1% +$1.11K 0.01% 803
2021
Q2
$97K Sell
14,730
-16,366
-53% -$114K 0.01% 761
2021
Q1
$252K Buy
31,096
+16,155
+108% +$132K 0.02% 649
2020
Q4
$96K Sell
14,941
-364
-2% -$2.12K 0.01% 587
2020
Q3
$55K Sell
15,305
-129
-0.8% -$521 0.01% 540
2020
Q2
$71K Sell
15,434
-1,977
-11% -$8.41K 0.01% 532
2020
Q1
$59K Buy
+17,411
New +$76.1K 0.01% 472
2019
Q4
Sell
-17,066
Closed -$41K 537
2019
Q3
$41K Sell
17,066
-860
-5% -$2.28K 0.01% 546
2019
Q2
$39K Buy
17,926
+348
+2% +$823 0.01% 544
2019
Q1
$48K Buy
+17,578
New +$76.1K 0.01% 523

Other funds holding IMGN

Vestmark Advisory Solutions's IMGN Position: Q4 2022 in Review

Vestmark Advisory Solutions sold out of Immunogen Inc (IMGN) in Q4 2022, closing a stake of 24,892 shares — an estimated $119K sold.

Vestmark Advisory Solutions first reported a position in IMGN in Q1 2019 and held it in 14 quarters. The position peaked at $252K in Q1 2021. 204 funds tracked by Wall St. Rank hold IMGN as of Q4 2022.

  • Vestmark Advisory Solutions reported no remaining Immunogen Inc position as of Q4 2022 after selling out during the quarter.
  • Vestmark Advisory Solutions sold 24,892 Immunogen Inc shares in Q4 2022, an estimated $119K.
  • Vestmark Advisory Solutions first reported a position in Immunogen Inc in Q1 2019 and held it in 14 quarters.
  • Vestmark Advisory Solutions's Immunogen Inc position peaked at $252K in Q1 2021.
  • 204 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2022.

Based on Vestmark Advisory Solutions's 13F filing for Q4 2022, filed 20 Jan 2023.